Syndecan-1和乙酰肝素酶1在结直肠癌中的表达及对其转移和预后的影响(3)
第1页 |
参见附件。
[10]Xu Y,Yuan J,Zhang Z,et al.Syndecan-1 expression in human glioma is correlated with advanced tumor progression and poor prognosis[J].Mol Biol Rep,2012,39(9):8979-8985.
[11]Shevelev OB,Rykova VI,Fedoseeva LA,et al.Expression of Ext1,Ext2,and heparanase genes in brain of senescence-accelerated OXYS rats in earlyontogenesis and during development of neurodegenerative changes[J].Biochemistry,2012,77(1):56-61.
[12]Rops AL,van den Hoven MJ,Veldman BA,et al.Urinary heparanase activity in patients with Type 1 and Type 2 diabetes[J].Nephrol Dial Transplant,2012,27(7):2853-2861.
[13]Peerless Y,Simon E,Sabo E,et al.Normal colon tissue and colon carcinoma show no difference in heparanase promoter methylation[J].Exp Mol Pathol,2013,94(2):309-313.
[14]Kutsenko OS,Kovner AV,Mostovich LA,et al.Expression of heparanase-1 in prostate gland tumors[J].Bull Exp Biol Med,2012,152(3):344-347.
[15]Baker AB,Gibson WJ,Kolachalama VB,et al.Heparanase regulates thrombosis in vascular injury and stent-induced flow disturbance[J].J Am Coll Cardiol,2012,59(17):1551-1560.
[16]Sung JJ,Lau JY,Goh KL,et al.Increasing incidence of colorectal cancer in Asia:implications for screening[J].Lancet Oncol,2005,6(11):87l-876.
(收稿日期:2014-03-18本文编辑:林利利)
您现在查看是摘要介绍页,详见PDF附件。